{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T05:24:01Z","timestamp":1748237041451},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,2,28]],"date-time":"2011-02-28T00:00:00Z","timestamp":1298851200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2011,2,28]],"date-time":"2011-02-28T00:00:00Z","timestamp":1298851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Observational studies suggest statin therapy reduces incident sepsis, but few studies have examined the impact on new organ failure. We tested the hypothesis that statin therapy, administered for standard clinical indications to ventilated intensive care unit patients, prevents acute organ failure without harming the liver.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>We performed a retrospective, single-centre cohort study in a tertiary mixed medical\/surgical intensive care unit. Mechanically ventilated patients without nonrespiratory organ failure within 24 hours after admission were assessed (during the first 15 days) for new acute organ failure (defined as Sequential Organ Failure Assessment (SOFA) score 3 or 4), liver failure (defined as new hepatic SOFA \u22653, or a 1.5 times increase of bilirubin from baseline to a value \u226520 mmol\/l), and alanine transferase (ALT) &gt; 165 IU\/l. The effect of statin administration was explored in generalised linear mixed models.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>A total of 1,397 patients were included. Two hundred and nineteen patients received a median (interquartile range) of three (two, eight) statin doses. Patients receiving statins were older (67.4 vs. 55.5 years, <jats:italic>P<\/jats:italic> &lt; 0.0001), less likely female (25.1% vs. 37.9%, <jats:italic>P<\/jats:italic> = 0.0003) and sicker (Acute Physiology and Chronic Health Evaluation (APACHE) II score 20.3 vs. 17.8, <jats:italic>P<\/jats:italic> &lt; 0.0001). Considering outcome events at least 1 day after statin administration, statin patients were equally likely to develop acute organ failure (28.4% vs. 22.3%, <jats:italic>P<\/jats:italic> = 0.29) and hepatic failure (9.5% vs. 7.6%, <jats:italic>P<\/jats:italic> = 0.34), but were more likely to experience an ALT increase to &gt; 165 IU\/l ((11.2% vs. 4.8%, <jats:italic>P<\/jats:italic> = 0.0005). Multivariable analysis showed that APACHE II score (odds ratio (OR) = 1.05 per point; 95% confidence interval (CI) = 1.03 to 1.07) and APACHE II admission category (<jats:italic>P<\/jats:italic> &lt; 0.0001), but not statin administration (OR = 1.21; 95% CI = 0.92 to 1.62), were significantly associated with acute organ failure occurring on or after the day of first statin administration. Statin administration was not associated with liver impairment (OR = 1.08; 95% CI = 0.66 to 1.77) but was associated with a rise in ALT &gt; 165 IU\/l (OR = 2.25; 95% CI = 1.32 to 3.84), along with APACHE II score (<jats:italic>P<\/jats:italic> = 0.016) and admission ALT (<jats:italic>P<\/jats:italic> = 0.0001).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>Concurrent statin therapy does not appear to protect against the development of new acute organ failure in critically ill, ventilated patients. The lack of effect may be due to residual confounding, a relatively low number of doses received, or an absence of true effect. Randomised controlled trials are needed to confirm a protective effect.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/cc10063","type":"journal-article","created":{"date-parts":[[2011,3,2]],"date-time":"2011-03-02T00:03:48Z","timestamp":1299024228000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Statins do not prevent acute organ failure in ventilated ICU patients: single-centre retrospective cohort study"],"prefix":"10.1186","volume":"15","author":[{"given":"Marius J","family":"Terblanche","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruxandra","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Whiteley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Brett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Beale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neill KJ","family":"Adhikari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,2,28]]},"reference":[{"key":"9340_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1164\/rccm.200403-324OC","volume":"171","author":"C Alberti","year":"2005","unstructured":"Alberti C, Brun-Buisson C, Chevret S, Antonelli M, Goodman SV, Martin C, Moreno R, Ochagavia AR, Palazzo M, Werdan K, Le Gall JR: Systemic inflammatory response and progression to severe sepsis in critically ill infected patients.\n                           Am J Respir Crit Care Med 2005, 171: 461-468. 10.1164\/rccm.200403-324OC","journal-title":"Am J Respir Crit Care Med"},{"key":"9340_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1001\/jama.1995.03520260039030","volume":"273","author":"MS Rangel-Frausto","year":"1995","unstructured":"Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP: The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study.\n                           JAMA 1995, 273: 117-123. 10.1001\/jama.273.2.117","journal-title":"JAMA"},{"issue":"Suppl 1","key":"9340_CR3","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.1007\/s001340051121","volume":"26","author":"C Brun-Buisson","year":"2000","unstructured":"Brun-Buisson C: The epidemiology of the systemic inflammatory response.\n                           Intensive Care Med 2000,26(Suppl 1):S64-S74. 10.1007\/s001340051121","journal-title":"Intensive Care Med"},{"key":"9340_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1164\/rccm.200208-785OC","volume":"168","author":"C Alberti","year":"2003","unstructured":"Alberti C, Brun-Buisson C, Goodman SV, Guidici D, Granton J, Moreno R, Smithies M, Thomas O, Artigas A, Le Gall JR: Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients.\n                           Am J Respir Crit Care Med 2003, 168: 77-84. 10.1164\/rccm.200208-785OC","journal-title":"Am J Respir Crit Care Med"},{"key":"9340_CR5","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1097\/00003246-199812000-00001","volume":"26","author":"C Natanson","year":"1998","unstructured":"Natanson C, Esposito CJ, Banks SM: The sirens' songs of confirmatory sepsis trials: selection bias and sampling error.\n                           Crit Care Med 1998, 26: 1927-1931. 10.1097\/00003246-199812000-00001","journal-title":"Crit Care Med"},{"key":"9340_CR6","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1164\/rccm.200810-1584OC","volume":"179","author":"M Shyamsundar","year":"2009","unstructured":"Shyamsundar M, McKeown ST, O'Kane CM, Craig TR, Brown V, Thickett DR, Matthay MA, Taggart CC, Backman JT, Elborn JS, McAuley DF: Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers.\n                           Am J Respir Crit Care Med 2009, 179: 1107-1114. 10.1164\/rccm.200810-1584OC","journal-title":"Am J Respir Crit Care Med"},{"key":"9340_CR7","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s00134-009-1429-0","volume":"35","author":"V Novack","year":"2009","unstructured":"Novack V, Eisinger M, Frenkel A, Terblanche M, Adhikari NK, Douvdevani A, Amichay D, Almog Y: The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial.\n                           Intensive Care Med 2009, 35: 1255-1260. 10.1007\/s00134-009-1429-0","journal-title":"Intensive Care Med"},{"key":"9340_CR8","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S1473-3099(06)70439-X","volume":"6","author":"M Terblanche","year":"2006","unstructured":"Terblanche M, Almog Y, Rosenson RS, Smith TS, Hackam DG: Statins: panacea for sepsis?\n                           Lancet Infect Dis 2006, 6: 242-248. 10.1016\/S1473-3099(06)70439-X","journal-title":"Lancet Infect Dis"},{"key":"9340_CR9","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S1473-3099(07)70111-1","volume":"7","author":"M Terblanche","year":"2007","unstructured":"Terblanche M, Almog Y, Rosenson RS, Smith TS, Hackam DG: Statins and sepsis: multiple modifications at multiple levels.\n                           Lancet Infect Dis 2007, 7: 358-368. 10.1016\/S1473-3099(07)70111-1","journal-title":"Lancet Infect Dis"},{"key":"9340_CR10","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/cc5056","volume":"10","author":"M Terblanche","year":"2006","unstructured":"Terblanche M, Smith TS, Adhikari NK: Statins, bugs and prophylaxis: intriguing possibilities.\n                           Crit Care 2006, 10: 168. 10.1186\/cc5056","journal-title":"Crit Care"},{"key":"9340_CR11","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1093\/jac\/dkn019","volume":"61","author":"ME Falagas","year":"2008","unstructured":"Falagas ME, Makris GC, Matthaiou DK, Rafailidis PI: Statins for infection and sepsis: a systematic review of the clinical evidence.\n                           J Antimicrob Chemother 2008, 61: 774-785. 10.1093\/jac\/dkn019","journal-title":"J Antimicrob Chemother"},{"key":"9340_CR12","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1001\/archinternmed.2009.286","volume":"169","author":"IM Tleyjeh","year":"2009","unstructured":"Tleyjeh IM, Kashour T, Hakim FA, Zimmerman VA, Erwin PJ, Sutton AJ, Ibrahim T: Statins for the prevention and treatment of infections: a systematic review and meta-analysis.\n                           Arch Intern Med 2009, 169: 1658-1667. 10.1001\/archinternmed.2009.286","journal-title":"Arch Intern Med"},{"key":"9340_CR13","doi-asserted-by":"publisher","first-page":"52C","DOI":"10.1016\/j.amjcard.2005.12.010","volume":"97","author":"M Law","year":"2006","unstructured":"Law M, Rudnicka AR: Statin safety: a systematic review.\n                           Am J Cardiol 2006, 97: 52C-60C. 10.1016\/j.amjcard.2005.12.010","journal-title":"Am J Cardiol"},{"key":"9340_CR14","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine.\n                           Intensive Care Med 1996, 22: 707-710. 10.1007\/BF01709751","journal-title":"Intensive Care Med"},{"key":"9340_CR15","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","volume":"13","author":"WA Knaus","year":"1985","unstructured":"Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system.\n                           Crit Care Med 1985, 13: 818-829. 10.1097\/00003246-198510000-00009","journal-title":"Crit Care Med"},{"key":"9340_CR16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s00134-005-2743-9","volume":"32","author":"R Fernandez","year":"2005","unstructured":"Fernandez R, De Pedro VJ, Artigas A: Statin therapy prior to ICU admission: protection against infection or a severity marker?\n                           Intensive Care Med 2005, 32: 160-164. 10.1007\/s00134-005-2743-9","journal-title":"Intensive Care Med"},{"key":"9340_CR17","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1007\/s00134-006-0246-y","volume":"32","author":"H Schmidt","year":"2006","unstructured":"Schmidt H, Hennen R, Keller A, Russ M, Muller-Werdan U, Werdan K, Buerke M: Association of statin therapy and increased survival in patients with multiple organ dysfunction syndrome.\n                           Intensive Care Med 2006, 32: 1248-1251. 10.1007\/s00134-006-0246-y","journal-title":"Intensive Care Med"},{"key":"9340_CR18","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1592\/phco.29.6.621","volume":"29","author":"PP Dobesh","year":"2009","unstructured":"Dobesh PP, Klepser DG, McGuire TR, Morgan CW, Olsen KM: Reduction in mortality associated with statin therapy in patients with severe sepsis.\n                           Pharmacotherapy 2009, 29: 621-630. 10.1592\/phco.29.6.621","journal-title":"Pharmacotherapy"},{"key":"9340_CR19","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1016\/j.lpm.2009.09.022","volume":"39","author":"L de Saint Martin","year":"2010","unstructured":"de Saint Martin L, Tande D, Goetghebeur D, Pan-Lamande M, Segalen Y, Pasquier E: Statin use does not affect the outcome of acute infection: a prospective cohort study.\n                           Presse Med 2010, 39: e52-e57. 10.1016\/j.lpm.2009.09.022","journal-title":"Presse Med"},{"key":"9340_CR20","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s00134-009-1421-8","volume":"35","author":"DJ Kor","year":"2009","unstructured":"Kor DJ, Iscimen R, Yilmaz M, Brown MJ, Brown DR, Gajic O: Statin administration did not influence the progression of lung injury or associated organ failures in a cohort of patients with acute lung injury.\n                           Intensive Care Med 2009, 35: 1039-1046. 10.1007\/s00134-009-1421-8","journal-title":"Intensive Care Med"},{"key":"9340_CR21","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1161\/01.CIR.0000012530.68333.C8","volume":"105","author":"C Heeschen","year":"2002","unstructured":"Heeschen C, Hamm CW, Laufs U, Snapinn S, Bohm M, White HD: Withdrawal of statins increases event rates in patients with acute coronary syndromes.\n                           Circulation 2002, 105: 1446-1452. 10.1161\/01.CIR.0000012530.68333.C8","journal-title":"Circulation"},{"key":"9340_CR22","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1164\/rccm.201006-0955OC","volume":"183","author":"PS Kruger","year":"2011","unstructured":"Kruger PS, Harward ML, Jones MA, Joyce CJ, Kostner KM, Roberts MS, Venkatesh B: Continuation of statin therapy in patients with presumed infection: a randomised controlled trial.\n                           Am J Respir Crit Care Med 2011, 183: 774-781. 10.1164\/rccm.201006-0955OC","journal-title":"Am J Respir Crit Care Med"},{"key":"9340_CR23","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00134-008-1358-3","volume":"35","author":"PS Kruger","year":"2009","unstructured":"Kruger PS, Freir NM, Venkatesh B, Robertson TA, Roberts MS, Jones M: A preliminary study of atorvastatin plasma concentrations in critically ill patients with sepsis.\n                           Intensive Care Med 2009, 35: 717-721. 10.1007\/s00134-008-1358-3","journal-title":"Intensive Care Med"},{"key":"9340_CR24","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1097\/CCM.0b013e3181b7fbbb","volume":"37","author":"AK Shintani","year":"2009","unstructured":"Shintani AK, Girard TD, Eden SK, Arbogast PG, Moons KG, Ely EW: Immortal time bias in critical care research: application of time-varying Cox regression for observational cohort studies.\n                           Crit Care Med 2009, 37: 2939-2945. 10.1097\/CCM.0b013e3181b7fbbb","journal-title":"Crit Care Med"},{"key":"9340_CR25","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1164\/rccm.201003-0423OC","volume":"183","author":"TR Craig","year":"2011","unstructured":"Craig TR, Duffy MJ, Shyamsundar M, McDowell C, C OK, Elborn JS, McAuley DF: A randomized clinical trial of hydroxymethylglutaryl-CoA reductase inhibition for acute lung injury (the HARP study).\n                           Am J Respir Crit Care Med 2011, 183: 620-626. 10.1164\/rccm.201003-0423OC","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc10063.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/cc10063\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc10063.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T12:24:38Z","timestamp":1728303878000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/cc10063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,28]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2011,2]]}},"alternative-id":["9340"],"URL":"https:\/\/doi.org\/10.1186\/cc10063","relation":{},"ISSN":["1364-8535"],"issn-type":[{"type":"electronic","value":"1364-8535"}],"subject":[],"published":{"date-parts":[[2011,2,28]]},"assertion":[{"value":"25 October 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R74"}}